pyrazines has been researched along with dabigatran in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
De Nanteuil, G; Gloanec, P; Marx, I; Mennecier, P; Rupin, A; Vallez, MO; Verbeuren, TJ | 1 |
Fu, L; Jiang, F; Jin, Y; Liu, J; Liu, W; Zhang, Y | 1 |
Diao, XJ; Gong, GQ; He, GW; Xu, YG; Yang, WH; Yang, XZ | 1 |
3 other study(ies) available for pyrazines and dabigatran
Article | Year |
---|---|
S35972, a direct-acting thrombin inhibitor with high oral bioavailability and antithrombotic efficacy.
Topics: Administration, Oral; Animals; Anticoagulants; Benzimidazoles; Biological Availability; Blood Coagulation Tests; Dabigatran; Disease Models, Animal; Dogs; Drug Evaluation; Humans; In Vitro Techniques; Inhibitory Concentration 50; Pyrazines; Pyridines; Pyrroles; Rats; Thrombin; Thrombosis | 2011 |
Design, synthesis, and evaluation of 2-substituted ethenesulfonic acid ester derivatives as protein tyrosine phosphatase 1B inhibitors.
Topics: Adenosine Diphosphate; Animals; Benzimidazoles; Blood Platelets; Dabigatran; Drug Design; Esters; Inhibitory Concentration 50; Magnetic Resonance Spectroscopy; Microsomes, Liver; Platelet Aggregation; Platelet Aggregation Inhibitors; Prodrugs; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Pyrazines; Pyridines; Rabbits; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; Thrombin; Venous Thrombosis | 2012 |
Synthesis and antithrombotic evaluation of novel dabigatran prodrugs containing a cleavable moiety with anti-platelet activity.
Topics: Adenosine Diphosphate; Animals; Benzimidazoles; Blood Platelets; Dabigatran; Drug Design; Inhibitory Concentration 50; Magnetic Resonance Spectroscopy; Microsomes, Liver; Platelet Aggregation; Platelet Aggregation Inhibitors; Prodrugs; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Pyrazines; Pyridines; Rabbits; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; Thrombin; Venous Thrombosis | 2012 |